Skip to content

What is Lipid 20%? An Intravenous Fat Emulsion Explained

4 min read

Intravenous fat emulsions, including lipid 20%, have been used in medicine since the 1960s to provide nutrients to patients who cannot consume food orally. Administered directly into the bloodstream, this sterile solution supplies essential calories and fatty acids critical for energy and metabolic function.

Quick Summary

Lipid 20% is an intravenous fat emulsion that provides calories and essential fatty acids, primarily used in parenteral nutrition and as an antidote for local anesthetic toxicity.

Key Points

  • Source of Nutrition: Lipid 20% provides calories and essential fatty acids for patients who cannot eat, a process known as parenteral nutrition.

  • Emergency Antidote: It is the standard treatment for local anesthetic systemic toxicity (LAST) and cardiac arrest caused by certain medications.

  • 'Lipid Sink' Mechanism: In cases of toxicity, the emulsion creates a fat-rich environment in the bloodstream that draws out the toxic, lipid-soluble drug.

  • Formulation: Standard lipid 20% is typically composed of soybean oil, egg yolk phospholipids, and glycerin.

  • Monitoring is Key: Patients receiving lipid 20% must be monitored for side effects like hypertriglyceridemia, fat overload syndrome, and potential liver complications.

  • Risks for Vulnerable Patients: Infants, particularly preemies, are at a higher risk of adverse effects from rapid infusion or long-term use.

In This Article

What is Lipid 20%?

Lipid 20% is a specific concentration of an intravenous fat emulsion (IVFE), a sterile, milky-white solution that delivers fat directly into a patient’s bloodstream. It is a fundamental component of parenteral nutrition (PN), also known as intravenous or IV feeding. The '20%' refers to the concentration of fat in the solution, meaning there are 20 grams of fat for every 100 milliliters of the emulsion.

Unlike traditional food intake, this method bypasses the digestive system entirely, making it vital for individuals with compromised gastrointestinal function or specific nutritional needs. Different formulations of lipid emulsions exist, but the 20% concentration is widely used and provides a high caloric density, approximately 2 kcal/mL.

The Role in Medical Nutrition

For patients on extended PN (typically more than 5 days), lipid 20% plays several key roles. It provides a concentrated source of energy, reduces the amount of glucose needed, and prevents essential fatty acid deficiency (EFAD), a serious condition that can result from a lack of dietary fats. The emulsion also helps with the absorption of fat-soluble vitamins.

Common Components of Lipid 20%

While brand names and formulations can differ, a standard lipid 20% emulsion like Intralipid® is comprised of several key ingredients:

  • Soybean Oil: The primary source of fat, containing a mixture of saturated and unsaturated fatty acids, notably linoleic and linolenic acids.
  • Egg Yolk Phospholipids: These act as the emulsifying agent, preventing the separation of the oil and water components and keeping the fat particles stable and uniformly dispersed.
  • Glycerin: A stabilizing agent that makes the solution isotonic with blood, helping to prevent irritation of the veins during infusion.
  • Water for Injection: The sterile, pyrogen-free water that forms the base of the emulsion.

Medical Applications

Beyond basic nutrition, lipid 20% has critical applications in emergency medicine. One such application is known as 'Lipid Rescue'.

  • Parenteral Nutrition (PN): The main use for lipid 20% is in PN, providing vital energy and essential fatty acids for patients who cannot eat normally. This includes patients with bowel disorders, severe malnutrition, or those recovering from major surgery.
  • Local Anesthetic Systemic Toxicity (LAST): In cases of accidental intravascular injection of local anesthetics, which can cause cardiovascular collapse, a 20% lipid emulsion is administered intravenously. The accepted mechanism, known as the 'lipid sink' theory, suggests the emulsion creates a lipid phase in the blood that draws the fat-soluble anesthetic away from target organs like the heart and brain, effectively reversing its toxic effects.

Understanding the 'Lipid Sink' Effect

The 'lipid sink' phenomenon is a cornerstone of lipid rescue therapy. When a toxic dose of a lipid-soluble drug, like bupivacaine, is injected into the bloodstream, it readily binds to the body's natural lipids. By infusing a large amount of lipid 20%, medical professionals can expand the volume of the lipid phase in the blood. This increased volume creates a 'sink' that attracts the drug molecules, pulling them away from sensitive tissue receptors in the heart and central nervous system. This effectively lowers the concentration of the free drug, allowing the patient's body to recover.

Potential Risks and Monitoring

Despite its life-saving benefits, the administration of lipid 20% is not without risks and requires careful monitoring, especially in sensitive populations like infants.

Potential Complication Description Monitoring Who is at risk?
Hypertriglyceridemia Excessively high levels of triglycerides in the blood, indicating impaired lipid clearance. Regular serum triglyceride level checks. Patients with underlying lipid disorders, obesity, diabetes, or metabolic syndrome.
Fat Overload Syndrome A rare but serious condition causing sudden deterioration with fever, anemia, and organ enlargement. Close monitoring for symptoms; triglyceride checks. Exceeding recommended dose/rate, especially in those with poor lipid clearance.
Liver Disease (PNALD) Long-term use can lead to liver disease, presenting as cholestasis or hepatic steatosis. Regular liver function tests (LFTs). Patients on long-term PN, especially infants and preterm neonates.
Hypersensitivity Allergic reactions due to components like egg yolk or soybean oil. Monitoring for signs like rash, swelling, or breathing issues. Patients with known egg, soybean, or peanut allergies.
Aluminum Toxicity Accumulation of aluminum, particularly in patients with renal impairment. Regular monitoring, especially in preterm infants. Patients with impaired kidney function, premature neonates.

Conclusion

Lipid 20% is a critical medical product with dual applications: providing necessary nutrition via total parenteral nutrition and acting as a life-saving antidote in local anesthetic toxicity emergencies. Its composition, typically based on soybean oil, egg phospholipids, and glycerin, provides a concentrated source of calories and essential fatty acids. However, its use requires careful medical oversight to monitor for potential side effects such as hypertriglyceridemia and fat overload syndrome, particularly during prolonged administration or in high-risk patient groups like infants. As with any medication, its administration must be based on a careful benefit-risk assessment by a qualified healthcare professional. For more details on the use of fat emulsions in parenteral nutrition, authoritative information can be found at resources like the American Society for Parenteral and Enteral Nutrition (ASPEN).

Medical Disclaimer: The information provided in this article is for informational purposes only and does not constitute medical advice. For any medical concerns or before starting any treatment, consult with a qualified healthcare professional.

Frequently Asked Questions

The primary purpose is to serve as a source of calories and essential fatty acids for patients requiring parenteral nutrition (IV feeding) for an extended period.

Lipid 20% is a more concentrated solution, providing more calories per milliliter. Studies have shown that 20% emulsions may be associated with fewer lipoprotein abnormalities compared to 10% in some patient populations, especially infants.

'Lipid Rescue' is the use of intravenous lipid emulsion therapy to reverse local anesthetic systemic toxicity (LAST), a severe and potentially fatal complication of regional anesthesia. It is used as an antidote, particularly for cardiac arrest that is unresponsive to standard resuscitation measures.

Common side effects include nausea, vomiting, fever, headache, flushing, and irritation at the infusion site. More serious complications like liver dysfunction, hypertriglyceridemia, and fat overload syndrome can also occur.

Yes, lipid 20% is contraindicated in patients with severe disorders of fat metabolism, such as pathologic hyperlipemia, and those with known hypersensitivity to eggs, soybeans, or peanuts.

Yes, but with extreme caution. Premature and low birth-weight infants have poor fat clearance, and rapid infusion can be very dangerous. Close monitoring of triglyceride levels is mandatory in pediatric patients.

Medical staff must regularly monitor serum triglyceride levels to ensure proper fat elimination. For long-term use, liver function tests are also performed. Clinical signs of infection or fat overload syndrome are continuously assessed.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.